Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study.
Caturano A, Galiero R, Loffredo G, Vetrano E, Medicamento G, Acierno C, Rinaldi L, Marrone A, Salvatore T, Monda M, Sardu C, Marfella R, Sasso FC. Caturano A, et al. Among authors: acierno c. Biomedicines. 2023 Jan 23;11(2):322. doi: 10.3390/biomedicines11020322. Biomedicines. 2023. PMID: 36830859 Free PMC article.
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial.
Sasso FC, Simeon V, Galiero R, Caturano A, De Nicola L, Chiodini P, Rinaldi L, Salvatore T, Lettieri M, Nevola R, Sardu C, Docimo G, Loffredo G, Marfella R, Adinolfi LE, Minutolo R; NID-2 study group Investigators. Sasso FC, et al. Cardiovasc Diabetol. 2022 Nov 7;21(1):235. doi: 10.1186/s12933-022-01674-7. Cardiovasc Diabetol. 2022. PMID: 36344978 Free PMC article. Clinical Trial.
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease.
Sasso FC, Pafundi PC, Simeon V, De Nicola L, Chiodini P, Galiero R, Rinaldi L, Nevola R, Salvatore T, Sardu C, Marfella R, Adinolfi LE, Minutolo R; NID-2 Study Group Investigators. Sasso FC, et al. Cardiovasc Diabetol. 2021 Jul 16;20(1):145. doi: 10.1186/s12933-021-01343-1. Cardiovasc Diabetol. 2021. PMID: 34271948 Free PMC article. Clinical Trial.
Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals.
Nevola R, Rinaldi L, Zeni L, Romano C, Marrone A, Galiero R, Pafundi PC, Acierno C, Vetrano E, Adinolfi LE. Nevola R, et al. Among authors: acierno c. Expert Rev Gastroenterol Hepatol. 2021 Jun;15(6):643-656. doi: 10.1080/17474124.2021.1877136. Epub 2021 Feb 15. Expert Rev Gastroenterol Hepatol. 2021. PMID: 33445990 Review.
Metformin: A Potential Therapeutic Tool for Rheumatologists.
Salvatore T, Pafundi PC, Galiero R, Gjeloshi K, Masini F, Acierno C, Di Martino A, Albanese G, Alfano M, Rinaldi L, Sasso FC. Salvatore T, et al. Among authors: acierno c. Pharmaceuticals (Basel). 2020 Sep 4;13(9):234. doi: 10.3390/ph13090234. Pharmaceuticals (Basel). 2020. PMID: 32899806 Free PMC article. Review.
Aspirin in a diabetic retinopathy setting: Insights from NO BLIND study.
Pafundi PC, Galiero R, Caturano A, Acierno C, de Sio C, Vetrano E, Nevola R, Gelso A, Bono V, Costagliola C, Marfella R, Sardu C, Rinaldi L, Salvatore T, Adinolfi LE, Sasso FC; No Blind Study Group. Pafundi PC, et al. Among authors: acierno c. Nutr Metab Cardiovasc Dis. 2020 Sep 24;30(10):1806-1812. doi: 10.1016/j.numecd.2020.06.021. Epub 2020 Jun 29. Nutr Metab Cardiovasc Dis. 2020. PMID: 32736957
27 results